August 2020
A retrospective study of 2,032 solid organ transplant recipients (SOTR) between 1993 and 2016 examined rates of skin cancer and dermatoses in a Hispanic-majority population.
Why this matters
A retrospective study of 2,032 solid organ transplant recipients (SOTR) between 1993 and 2016 examined rates of skin cancer and dermatoses in a Hispanic-majority population. This work contributes to evidence-based plastic and reconstructive surgery — helping clinicians interpret outcomes, refine technique, and counsel patients with clearer data.
Author
Plastic and reconstructive surgery resident at Emory University (UCLA BS, USC MD) with an h-index of 15 and peer-reviewed work spanning aesthetic surgery, reconstruction, medical devices, and AI in medicine.
Abstract
A retrospective study of 2,032 solid organ transplant recipients (SOTR) between 1993 and 2016 examined rates of skin cancer and dermatoses in a Hispanic-majority population. Of the patients, 52.1% were Hispanic, with 15.5% diagnosed with skin cancer or dermatoses. Skin cancer was found in 16.8% of Hispanics compared to 39.8% in non-Hispanic white (NHW) patients. Squamous cell carcinoma (SCC) was the most common skin cancer in both groups, but Hispanics had fewer cases and were less likely to have multiple skin cancers. Hispanics had a significantly higher rate of fungal infections (28.0%) compared to other groups. The study highlights that Hispanic SOTR face an elevated risk for skin cancer and other dermatoses. However, the results may not be generalizable to all Hispanic populations, and larger prospective studies are needed to better understand racial/ethnic differences in post-transplant skin conditions.